Details of the Drug

General Information of Drug (ID: DMFYJXP)

Drug Name
MK-2640
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 1 [1]
Cross-matching ID
TTD ID
D0LR1Z

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)